Literature DB >> 9792301

Patterns of cytokine expression in AIDS-related non-Hodgkin's lymphoma.

C Pastore1, G Gaidano, P Ghia, L Fassone, A M Cilia, A Gloghini, D Capello, D Buonaiuto, S Gonella, S Roncella, A Carbone, G Saglio.   

Abstract

The pathogenesis of AIDS-related non-Hodgkin's lymphomas (AIDS-NHL) involves accumulation of genetic lesions, stimulation and selection by antigen, as well as infection by viruses. Deregulation of cytokine loops has also been proposed to contribute to AIDS-NHL development, although data are available only for a limited number of cytokines. In this study we have utilized a panel of AIDS-NHL cell lines to investigate in detail the pattern of tumour expression and production of a wide spectrum of cytokines. The cytokines investigated included interleukin (IL)-1alpha, IL-1beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-13, TNF alpha, TNF beta, IFN gamma, TGF beta2, G-CSF, GM-CSF and SCF. The AIDS-NHL cell lines utilized were representative of both AIDS-related Burkitt lymphoma (AIDS-BL) and AIDS-related body cavity-based lymphoma (AIDS-BCBL). Overall, AIDS-NHL were found to produce IL-6, IL-10 and TNF beta, although with different patterns depending upon the biological features of the tumour. Production of high levels of IL10 preferentially associated with Epstein-Barr virus (EBV) positive AIDS-BL and AIDS-BCBL, although lower levels of the cytokine were also detectable among EBV-negative AIDS-BL. Production of IL-6 was restricted to EBV-positive AIDS-BL and AIDS-BCBL, whereas it was absent among EBV-negative AIDS-BL. Production of TNF beta clustered with AIDS-BL, whereas this was absent among AIDS-BCBL. These results define that the pattern of cytokine expression of AIDS-NHL depends upon the biological features of the tumour and may have implications for the pathogenesis of these disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792301     DOI: 10.1046/j.1365-2141.1998.00927.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study.

Authors:  Hui-Lee Wong; Elizabeth C Breen; Ruth M Pfeiffer; Brahim Aissani; Jeremy J Martinson; Joseph B Margolick; Richard A Kaslow; Lisa P Jacobson; Richard F Ambinder; Stephen Chanock; Otoniel Martínez-Maza; Charles S Rabkin
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

Review 2.  AIDS related systemic non-Hodgkin's lymphoma.

Authors:  T Powles; G Matthews; M Bower
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

3.  Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).

Authors:  Marta Epeldegui; Jeannette Y Lee; Anna C Martínez; Daniel P Widney; Larry I Magpantay; Deborah Regidor; Ronald Mitsuyasu; Joseph A Sparano; Richard F Ambinder; Otoniel Martínez-Maza
Journal:  Clin Cancer Res       Date:  2015-09-17       Impact factor: 12.531

4.  Growth regulation of simian and human AIDS-related non-Hodgkin's lymphoma cell lines by TGF-beta1 and IL-6.

Authors:  Kristin R Ruff; Adriane Puetter; Laura S Levy
Journal:  BMC Cancer       Date:  2007-02-26       Impact factor: 4.430

5.  Non-Hodgkin's Lymphoma of the mandible in HIV patient - A Rare Case Report.

Authors:  Mahesh Neerupakam; Jacob Prakash; Sridevi Koduri; Thejasri Vishnubhatla
Journal:  Contemp Clin Dent       Date:  2018 Jan-Mar

6.  Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells.

Authors:  Laura E Martínez; Tracy R Daniels-Wells; Yu Guo; Larry I Magpantay; Pierre V Candelaria; Manuel L Penichet; Otoniel Martínez-Maza; Marta Epeldegui
Journal:  Mol Cancer Ther       Date:  2021-06-22       Impact factor: 6.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.